DEA schedule

Is Inqovi a controlled substance?

Inqovi contains cedazuridine and decitabine. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Inqovi (cedazuridine and decitabine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and cedazuridine and decitabine is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Inqovi?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Inqovi
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances listcedazuridine and decitabine is not on the list

Inqovi NDC listings

NDC listings for Inqovi
NDCProductFormStrengthLabelerDEA schedule
64842-0727INQOVItablet, film coated100 mg/1; 35 mg/1Taiho Pharmaceutical Co., Ltd.None

Questions

Is Inqovi a controlled substance?

No. Inqovi (cedazuridine and decitabine) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and cedazuridine and decitabine is not on the DEA controlled substances list.

Is Inqovi a narcotic?

No. Inqovi (cedazuridine and decitabine) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Nucleoside Metabolic Inhibitor.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Inqovi

Try it on your own data today.

Free to start. Most teams are using it the same day.